Whether you’re curious about taking a psychedelics investment trip or a tie-dyed-in-the-wool public market backer, psychedelics conferences are the best way to keep on top… Read More »Psychedelics conference fever – another sector roundup
Drug science is all about timing. You can either take a preexisting molecule, which has benefits for alternative indications rather than what it’s originally on… Read More »BetterLife Pharma (BETR.C) products show promise, but how’s their timing?
BetterLife is a biotechnology company that develops and commercializes psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the… Read More »Analysis: BetterLife (BETR.C) implements a business-minded and cost-conscious approach to product research and development
In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders.… Read More »To Invest or Not: BetterLife Pharma (BETR.C)
BetterLife Pharma (BETR.CN) is a Biotech company focused on developing second generation psychedelic compounds and nutraceuticals. Their products will address the unmet needs in the… Read More »Chart Attack: BetterLife Pharma (BETR.C) Ranging but Needs a Catalyst to Breakout
